Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: Comparison of characteristics and early outcome in the German multicenter TAVI registry

Clinical Research in Cardiology

Volumn 101, Issue 12, 2012, Pages 973-981

  Abdel Wahab, Mohamed ^a   Zahn, Ralf ^b   Horack, Martin ^c   Gerckens, Ulrich ^d   Schuler, Gerhard ^e   Sievert, Horst ^f   Naber, Christoph ^g   Voehringer, Matthias ^h   Schäfer, Ulrich ⁱ   Senges, Jochen ^c   Richardt, Gert ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Clinical Center of Ludwigshafen   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Helios Hospital   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

^f CardioVascular Center Frankfurt   (Germany)

^g ELISABETH KRANKENHAUS ESSEN   (Germany)

^h ROBERT BOSCH HOSPITAL   (Germany)

ⁱ Asklepios Klinik Sankt Georg   (Germany)

Author keywords

Coronary artery disease; Outcome; Transcatheter aortic valve implantation

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANGINA PECTORIS; ANGIOGRAPHY; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; CATHETER; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DISEASE REGISTRY; ECHOCARDIOGRAPHY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; QUALITY OF LIFE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT DURATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CORONARY ARTERY DISEASE; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HOSPITAL MORTALITY; HUMANS; MALE; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871928522     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-012-0486-5     Document Type: Article

References (30)

1. Leon MB, Smith CR, Mack MJ, PARTNER Trial Investigators et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-1607
2. Smith CR, Leon MB, Mack MJ, PARTNER Trial Investigators et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187-2198
3. Figulla L, Neumann A, Figulla HR et al (2011) Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol 100:265-276
4. Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using second and current third generation self expanding CoreValve prosthesis. J Am Coll Cardiol 50:69-76 (Pubitemid 46970878)
5. Motloch LJ, Rottlaender D, Reda S et al (2012) Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol 101:45-53
6. Thomas M, Schymik G, Walther T et al (2010) Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122:62-69
7. Eltchaninoff H, Prat A, Gilard M et al (2011) Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 32:191-197
8. Zahn R, Gerckens U, Grube E et al (2011) Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32:198-204
9. Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299-308
10. Puls M, Viel T, Danner BC, Jacobshagen C, et al (2012) The riskto-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience. Clin Res Cardiol (Epub ahead of print)
11. Stewart BF, Siscovick D, Lind BK et al (1997) Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 29:630-634 (Pubitemid 27116107)
12. Lund O, Nielsen TT, Pilegaard HK, Magnussen K, Knudsen MA (1990) The influence of coronary artery disease and bypass grafting on early and late survival after valve replacement for aortic stenosis. J Thorac Cardiovasc Surg 100:327-337 (Pubitemid 20282083)
13. Iung B, Drissi MF, Michel PL et al (1993) Prognosis of valve replacement for aortic stenosis with or without coexisting coronary heart disease: a comparative study. J Heart Valve Dis 2:430-439
14. Edwards FH, Peterson ED, Coombs LP et al (2001) Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885-892 (Pubitemid 32202459)
15. Dewey TM, Brown DL, Herbert MA et al (2010) Effect of concomitant coronary artery disease on procedural, late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg 89:758-767
16. Masson JB, Lee M, Boone RH et al (2010) Impact of coronary artery disease on outcomes after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 76:165-173
17. Roques F, Nashef SA, Michel P (2001) Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the EuroSCORE pilot program. J Heart Valve Dis 10:572-577
18. Grube E, Buellesfeld L, Mueller R et al (2008) Progress and current status of percutaneous aortic valve replacement: results of three device generations of the Corevalve revalving system. Circ Cardiovasc Interv 1:167-175
19. Webb JG, Pasupati S, Humphries K et al (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116:755-763 (Pubitemid 47255993)
20. Leon MB, Piazza N, Nikolsky E et al (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 57:253-269
21. Exadactylos N, Sugrue DD, Oakley CM (1984) Prevalence of coronary artery disease in patients with isolated aortic valve stenosis. Br Heart J 51:121-124 (Pubitemid 14164663)
22. He GW, Acuff TE, Ryan WH et al (1994) Aortic valve replacement: determinants of operative mortality. Ann Thorac Surg 57:1140-1146 (Pubitemid 24204495)
23. Iung B, Baron G, Butchart EG et al (2003) A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on valvular heart disease. Eur Heart J 24:1231-1243 (Pubitemid 36834640)
24. Antonini-Canterin F, Leiballi E, Capanna M et al (2009) Association between carotid and coronary artery disease in patients with aortic valve stenosis: an angiographic study. Angiology 60:596-600
25. Wenaweser P, Pilgrim T, Guerios E et al (2011) Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. EuroIntervention 7:541-548
26. Gautier M, Pepin M, Himbert D et al (2011) Impact of coronary artery disease on indications for transcatheter aortic valve implantation and on procedural outcomes. EuroIntervention 7:549-555
27. Abdel-Wahab M, Mostafa AE, Richardt G (2012) A case of rotational atherectomy after implantation of the medtronic corevalve bioprosthesis. Clin Res Cardiol (Epub ahead of print)
28. Conradi L, Seiffert M, Franzen O et al (2011) First experience with transcatheter aortic valve implantation and concomitant percutaneous coronary intervention. Clin Res Cardiol 100:311-316
29. Abdel-Wahab M, Mostafa AE, Geist V et al (2012) Comparison of outcomes in patients having isolated transcatheter aortic valve implantation versus combined with pre-procedural percutaneous coronary intervention. Am J Cardiol 109:581-586
30. Mostafa AE, Geist V, Abdel-Wahab M (2011) Ad-hoc percutaneous coronary intervention and transcatheter aortic valve implantation as a combined transfemoral procedure. J Invasive Cardiol 23:E102-E105